Zusammenfassung der Ressource
Pharmacology
- Immuno-modulating drugs
- Cyclosporine
- Inhibs IL-2 production
- Binds cyclophilin
- Tacrolimus
- Inhibits IL-2
- Binds FK12-BP
- Sirolimus
- Inhibs mTOR (mammalian target of rapamycin
- Azathioprine
- Inhibs DNA synth required for lymphocyte proliferation
- Mycophenolate mofetil
- Inhibs DNA synth for lymphocyte proliferation
- Inhibs IMP dehydrogenase
- Prednisone
- Inhibs cytokine gene expression
- Basilixmab, Daclizumab
- Bind IL-2 receptor--> inhibits IL-2 binding
- Belatacept
- Directed against CD80 glycoprotein on APC
- Inhibs costume of T cell lymphocytes
- Anti-fungals
- Amphotericin B
- Mech Axn: Binds ergosterol in membrane-->forms pores--> electrolytes and cell content leak
- Adverse Affects--> fevers, chills, & flu like rxn, renal toxicity: hydrate and give electrolytes, anemia, Shake n Bake
- Indications: Systemic mycoses--> Cryptococcus, Blastomyces, Coccidioides, Coccidioides, Histoplasma, Candida, & Mucor
- Polyenes
- Nystatin
- Binds ergosterol: fungistatic or fungicidal
- Topical only-->adverse effects are too toxic for systemic use
- Indications: oral candidiasis, topical yeast infections--> vaginal candidiasis & intertrigo
- Flucytosine
- Converted by fungal enzyme cytosine deaminase to 5-fluorouracil-->inhibit NA synth
- Effects: Bone marrow suppression
- Indications: Systemic mycoses--> Cryptococcus
- Azoles
- Mech: inhibs 14-alpha demethylase--> key in ergosterol synth in fungi. Fungistatic
- Effects: Anti-androgen effects via inhibiting testosterone synthesis, gynecomastia (ketoconazole), inhibs CYP450
- Indication: Mild Systemic mycoses
- Fluconazole: Chronic suppression of Cryptococcus in immunosuppressed pts
- Itraconazole: Blastomyces, Coccidioides, Histoplasma
- Voriconazole: Aspergillus & Candida
- Isavuconazole: Aspergillus & Mucor
- Allylamine: Terbinafine
- Inhibs squalene epoxidate-->lanosterol synthesis & Fungicidal
- Effects: GIT upset, Hepatotoxicity, taste disturbance
- Indications: widespread dermatophyte infections & Onychomycosis
- Griseofulvin
- Mech: inhibits mitosis--> microtubule dysfunction, especially targets keratin containing tissues; nails, & Fungistatic
- Effects: Teratogenic, Disulfiram-like rxn, Neuro: confusion and HA, & induces CYP450
- Indication: Superficial infections & dermatophytes
- Echinocandins
- Mech: inhibs cell wall synth-->inhibs beta gluten synth, fungistatic or fungicidal
- Effects: Flushing-->histamine
- Indications: Aspergillosis and Candida
- Antivirals
- Acyclovir, Famciclovir, Valacyclovir
- Mech: Guanosine analogs-->inhibs viral DNA poly
- Indication in HSV/VZV
- Effects: Obstructive crystalline nephropathy-->acute renal failure, hydrate pt can prevent
- Ganciclovir and Valganciclovir
- Mech: Guanosine analog-->inhibits viral DNA poly
- Indication: CMV
- Effects: Bone Marrow Suppression
- Foscarnet
- Mech: Inhibs viral DNA & RNA poly
- Indication: Ganciclovir resistant CMV
- Effects: Renal toxicity & electrolyte abnormalities
- Cidofovir
- Mech: Inhibs DNA poly inhibits; uses host enzymes
- Indications: CMV retinitis, Acyclovir resistant HSV
- Effects: Renal toxicity. Coadmin with probenecid and hydrate
- Antibiotics
- Beta lactams
- Penicillins
- Penicillin G
- Mech: Inhibits bacterial cell wall synth-->bind and inhibits transpeptidases
- Indication: Strep, meningococcal, neurosyphili
- Effects: Immediate hypersensitivity, rash, and seizures
- Aminopenicillins
- Ampicillin and Amoxicillin
- G - coverage
- Penicillinase-resistant penicillins
- Methicillin, Nafcillin, Oxacillin, Cloxaccillin, Dicloxacillin
- Stability to staphylococcal beta lactamase
- Anti-pseudomonal penicillins
- Carbenicillin, Ticarcillin, piperacillin
- G- bacteria: P. aeruginosa, anaerobic bacteria
- Cephalosporins
- 1st gen: Cefazolin, Cephalexin (Keflex)
- G+
- 2nd gen: Cefoxitin, cefaclor, cefuroxime
- G+ some G-, anaerobes
- 3rd gen: Cefixime, Ceftriaxone, Cefotaxime, Ceftazidime
- Serious G- infections, Meningitis, Pseudomonas
- 4th gen: Cefepime
- Expanded coverage G+ and G- (Pseudomonas)
- 5th gen: Ceftaroline
- Broad spectrum against G+ & MRSA
- Effects: Hypersensitivity reactions, nephritis, granulocytopenia, and hemolytic anemia
- Local-->pain after IM & thrombophlebitis after IV
- Hypoprothrominemia (give K+) and bleeding (cefoperazone & cefotetan
- Disulfiram like reaction: Cefoperazone, cefotetan
- Beta-lactamase inhibitors: Clavulanic acid, Sulbactam, Tazobactam and Avibactam
- Monobactams
- Aztreoname
- Indication: pts with immediate hypersensitivity to penicillins
- Effects: No cross allergic reaction with penicillins
- Carbapenems
- Imipenem-cilastatin, Meropenem, Doripenem, Ertapenem
- Indication: G- rods, P. aeruginosa, G+ organisms, and anaerobes
- Toxicity: Seizures especially in renal failure or with high doses
- Glycopeptide
- Vancomycin
- Inhibs cell wall synthesis-->bind D-Ala D-Ala of peptidoglycan
- Resistance turns into D-Ala D-Lac
- Indication: Sepsis, endocarditis, meningitis and C. diff
- Toxcity: Red man Syndrome
- Daptomycin
- Mech: Binds cell membrane-->depolarize and rapid cell death, increase K+
- Indication G+ bacteria; sepsis and endocarditis
- Effects: Myopathy, increase CK
- Aminoglycosides
- Gentamicin, Amikacin, Neomycin, Streptomycin, Tobramycin
- Mech: Inhibits 30S-->initiation, misreading mRNA, breakup polysomes into nonfunctional monosomes
- Indication: bactericidal, synergistic against G+ w/ beta lactam or vanco, [dependent] killing, post-antibio effect
- Effects: Nephrotoxicity (revers), ototoxicity (irrevers), neuromuscular blockade
- Tetracyclines
- Tetracycline, Doxy (safe CKD), Mino, Erava, Sare, Omada, methe, tige(safe CKD)
- Mech: Bacteriostatic, passive diffusion, blocks 30S, block aminoacyl-tRNA to acceptor site on mRNA; no add of aa to growing peptide
- Indication: G+, G-, mycoplasma, Chlamydiae, Rickettsiae
- Effects: divalent cations inhibits oral absorption, GIT upset, hepatotoxicity, photosensitivity, deposition in bone and teeth
- Macrolides
- Erythromycin, azithromycin, clarithromycin
- Mech: binds 50S by peptidyltransferase center-->inhibs elongation-->blocks E site
- Indication: Bacteriostatic, Mycoplasma pneumonia, pertussis, Corynebacterium, Chlamydia
- Effect: CYP 450 inhibitor, GIT upset, QT prolongation
- Protein Synthesis Inhibitors
- Clindamycin
- Mech: inhibits 50S
- Indication: Bacteriostatic against susceptible bacteria, anaerobe infections
- Effects: C. difficile colitis
- Quinupristin-dalfopristin
- Mech: inhibits 50S
- Indication: Bactericidal, Staph, and Vance resistant strains of E. faecium
- Effects: Infusion related myalgias and arthralgia
- Chloramphenicol
- Mech: Inhibs 50S
- Effect: Dose related anemia, idiosyncratic aplastic anemia, gray baby syndrome
- Linezolid
- Mech: Inhibs 23S from binding to 50S
- Indication: MRSA, VRE
- Effect: Duration dependent bone marrow suppression, neuropathy, and optic neuritis, 5-HT syndrome when admin w/ other serotonergic drugs (SSRIs)
- Sulfonamides
- Sulfamethoxazole, Cotrimoxazole (TMZ-SMP), sulfadiazine, sulfadoxine, sulfacetamide
- TMZ-SMZ (Bactrim)
- Mech: inhibits folate synthesis and DHFR
- Indication: P. jiroveci, Toxoplasma gondii
- Effects: rash, fever, bone marrow suppression, hemolytic anemia in G6PD
deficiency, Stevens Johnson Syndorme, toxic epidermic necrolysis (TEN), kernicterus in newborns-->increased bilirubin leads to encephalopathy
- Like to be basic
- Fluoroquinolones
- Norfloxacin (G-), G+ & G- : Cipro, Oslo, Levi, Gemi, and G+:
Moxi
- Mech: Inhibs DNA replication-->binds DNA gyros (topo II) and topoisomerase IV
- Indication: G= and G+
- Effects: neurotoxicity, tendonitis
- Not advised in <18 y/o d/t damage growing cartilage and cause arthropathy, be careful of giving to patients with use of
corticosteroids, and do NOT give with antacids